Our vision is a world in which the most severe effects of autism do not occur.
Our mission is to detect and prevent Maternal Autoantibody Related Autism (MARA).
We can detect a child’s risk for developing autism using a simple blood test in the mother.
What we do
WHY IT MATTERS
MARAbio’s risk assessment test can detect MARA before symptoms develop. This provides families and their physicians with options to detect early, limit severity, and ultimately prevent this subtype of autism, through pre-pregnancy and post-natal interventions. More about why
“It's good to finally have answers...”
How we do it
Our precision technology uses a blood test in women to identify the presence of a distinct cluster of antibodies that lead to MARA. This enables the earliest available risk assessment for the development of autism in a child, even before clinical symptoms exist.
